News
5th November 2025
KRISHGEN ELISA CONTRIBUTES TO WHO/NIBSC COLLABORATIVE STUDY ON ANTI-ADALIMUMAB ANTIBODY STANDARDIZATION
Krishgen Biosystems, a global developer and manufacturer of ELISA kits for pharmacokinetic (PK), anti-drug antibody (ADA), and biocompatibility studies, is proud to announce its participation in a World Health Organization (WHO) and National Institute for Biological Standards and Control (NIBSC) collaborative study focused on the standardization of anti-Adalimumab antibodies.
5th November 2025
Krishgen Launches New Website with Online Purchasing and A Faster Search
Krishgen Biosystems has unveiled its redesigned website, featuring a streamlined interface, faster product search, and integrated online purchasing.
5th October 2025
Krishgen Presents Poster at CGT Conference, Vellore
Krishgen Biosystems showcased its latest innovation at the CGT Conference in Vellore — a Cross-Matrix Validated Human Cytokine ELISA.
1st October 2025
Product Launch: PrecisionBind Cytokine ELISA Kits
Krishgen Biosystems introduces its PrecisionBind Cytokine ELISA Kits — high-performance assays for accurate cytokine quantification in therapeutic antibody and cell-gene therapy research.
26th September 2025
Krishgen Wins Best Research Poster at PCG 2025 for Tirzepatide (Mounjaro®) ELISA Study
Krishgen Biosystems was honoured with the Best Research Poster Award at PCG 2025 for its study on the KRIBIOLISA™ Tirzepatide (Mounjaro®) ELISA.
23rd May 2025
Product Launch: Wide Coverage CHO HCP ELISA
Krishgen Biosystems announces the launch of its Wide Coverage CHO HCP ELISA, designed for comprehensive detection of host cell proteins across diverse CHO expression systems offering better coverage across host cell proteins.
17th October 2024
Krishgen Presents Poster for ADC Sacituzumab Govitecan at Festival of Biologics, Basel
At Festival of Biologics 2024 in San Diego, Krishgen Biosystems Pvt Ltd unveiled a poster showcasing its novel ELISA method for pharmacokinetic assessment (PKA) of the antibody-drug conjugate Sacituzumab Govitecan.
8th September 2024
PRODUCT LAUNCH: Biochemical Assays
We are proud to announce the launch of our validated, competitively priced biochemical assays for detection of various analytes in Metabolic pathways, cell viability studies and more. With over 200 Assay kits across various research types, this range is comprehensive and robust.
7th July 2024
Krishgen Biosystems is now Krishgen Biosystems Pvt Ltd
We are pleased to announce that 22 years after we were established as a proprietorship company, we are now a Private Limited company. Our CEO and COO transition as directors of the firm, and the transition will be complete in late 2024.
13th February 2024
PRODUCT LAUNCH: KRIBIOLISA™ High Five (H5) HCP ELISA
Krishgen Biosystems is proud to announce the launch of our newest product, the High Five (H5) HCP ELISA. This kit is designed with a direct sandwich assay format to quantitatively measure HCPs contamination in pharmaceutical products manufactured using the High Five Cells expression systems with better specificity and sensitivity than current market leaders.
1st October 2023
New Partnership with DBA Italia for Italy
Krishgen announces its new partnership with DBA Italia for distribution of Krishgen ELISA in Italy.
15th October 2023
Krishgen Presents Poster for Development & Validation of dsRNA ELISA
At the Festival of Biologics 2023, Krishgen Biosystems showcased its novel ELISA method specifically developed for detecting double-stranded RNA (dsRNA) impurities in biologic manufacturing.
15th September 2023
Validation Guides now Available on the Krishgen website
Krishgen now offers validation guides from recent lots of mAb / Biosimilar ELISA on our website for ready access. Discover how the kit has been validated and get in touch with our technical team for additional details.
1st August 2023
New Partnership with Alfa Quantum Labs for Venezuela
Krishgen announces its new partnership with Alfa Quantum Labs for distribution of Krishgen ELISA in Venezuela.
5 June, 2023
Krishgen Products are now available for purchase through Labscoop.com.
All ELISA manufactured by Krishgen are now available for purchase through the Labscoop.com marketplace.
15 May 2023
New Partnership: Denis Pharma for Distribution in Japan
Krishgen announces its new partnership with Denis Pharma KK for distribution of Krishgen ELISA in Japan.
14 April 2023
Meet us at AACR 2023, Orlando
Krishgen is exhibiting at AACR 2023 at booth 1073. We welcome you to meet us 14 - 19 April in Orlando.
31 March 2023
Krishgen’s Major Milestone: Celebrating 20 Years
Krishgen Biosystems is celebrating 20 years of dedicated service to the life sciences industry!
27 March 2023
CiteAb 2023: Highly Commended in the Innovation Award Category
Krishgen is proud to be highly commended in the Innovation Award category at the 2023 CiteAb awards.
25 December 2022
PRODUCT LAUNCH: Two new kits: CRM197 and dsRNA ELISA
Krishgen announces the launch of two new ELISA kits for use in vaccine production – the CRM197 ELISA and the dsRNA ELISA.
1 December 2022
PRODUCT LAUNCH: World's First: Bispecific Antibody Drug ELISA
We are proud to announce the launch of our new ELISA range for quantifying Bispecific Antibody Drugs in serum and plasma samples.
27 November 2022
New Partnership: Labclinics SA for Distribution in Spain and Portugal
We are happy to announce our new partnership with Labclinics SA for distribution of Krishgen ELISA in Spain and Portugal.
18 November 2022
New Partnership: American Research Products for Distribution in USA
Krishgen is happy to announce its second partnership in the US for distribution of Krishgen ELISA: American Research Products (ARP).
15 August 2022
60+ SARS-CoV-2 ELISA kits Now Available for Different Antigens and Antibodies
Our GENLISA SARS-CoV-2 ELISA kits for human and animal species now available as the widest range of 60plus kits to cover your research.
14 June 2022
Krishgen ELISA now listed on CiteAb with all Product Citations
Krishgen’s GENLISA and KRIBIOLISA ELISA kits are now available on CiteAb with updated product citations.
1 April 2022
Calling all Indian Scientists: Krishgen’s got a new India-Specific Website for you.
Krishgen is happy to announce the launch of a new, highly dedicated website for our customers in India. This website includes products, information, and technical assistance from all our principal partners. Visit now: www.krishgenbiosystems.com.
10 February 2022
New Manufacturing Lab Inaugurated in Bhiwandi, Mumbai
Krishgen Group is proud to announce the inauguration of our new manufacturing facility in Bhiwandi – just outside of Mumbai.
7 November 2021
PRODUCT LAUNCH: World’s Only: 350+ mAb-based Drug ELISA for PK Analysis
For pharmacokinetic analysis of therapeutic monoclonal antibody drugs, Krishgen launches a range of highly specific and validated ELISA.
18 October, 2021
PRODUCT LAUNCH: FastNuclease™ Endonuclease Serratia Marcescens ELISA
Announcing the launch of Krishgen’s Endonuclease S.marcescens ELISA for quantitative detection in samples.
14 October 2021
PRODUCT LAUNCH: KRIBIOLISA Protein L Ligand ELISA kit
Krishgen is happy to announce the launch of our new KRIBIOLISA Protein L Ligand Leakage ELISA kit for detection of protein L in purified samples.
2021
Krishgen invited to join NBRIC – National Biomedical Resource Indigenisation Consortium
Krishgen, as a budding manufacturer of immunoassays and antibodies in India, has been invited by the Indian Government to be a part of their Make-In-India endeavour – NBRIC.
July 13, 2020
National Biomedical Resources Indigenization Consortium (NBRIC)
National Biomedical Resources Indigenization Consortium (NBRIC) member, Krishgen Biosystems develops two assays for COVID-19 research
4 April 2016
Krishgen’s Major Milestone: 100+ Strong
Krishgen is proud to announce that the Krishgen team is now 100+ strong.
21 March 2013